osteoporosis

Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Yahoo/AP
Tue, 02/12/13 - 10:55 am
Amgen
UCB Pharmaceuticals
fractures
osteoporosis
romosozumab
Merck loses 'bellwether' Fosamax case
Fierce Pharma
Wed, 02/6/13 - 11:12 am
Merck
Fosamax
osteoporosis
Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib
Wall Street Cheat Street
Sun, 02/3/13 - 11:59 am
Merck
Odanacatib
osteoporosis
bone cancer
Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin
Yahoo
Tue, 01/15/13 - 11:55 am
Unigene
FDA
advisory panels
calcitonin salmon
osteoporosis
Will Merck's Odanacatib Sufficiently Fill Singulair's Void?
Motley Fool
Sat, 12/1/12 - 09:23 am
Merck
Odanacatib
osteoporosis
Merck osteoporosis drug builds bone density in mid-stage trial
Reuters
Sat, 10/13/12 - 12:31 pm
Merck
osteoporosis
Odanacatib
Another Approval for Amgen's Prolia
Yahoo/Zacks
Tue, 09/25/12 - 04:45 pm
Amgen
Prolia
Merck
Eli Lilly
osteoporosis
Bonalon Jelly 35 mg Approved as World’s First Oral Jelly for Osteoporosis
PharmaLive
Thu, 08/16/12 - 01:46 pm
Bonalon Jelly
osteoporosis
Japan
Teijin Pharma
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Fri, 07/20/12 - 09:30 am
Merck
Abbott Labs
Amgen
GSK
Pfizer
Eli Lilly
osteoporosis
Odanacatib
Merck Hits 4-Year High As Osteoporosis Drug Shines
Investors.com
Thu, 07/12/12 - 11:23 am
Merck
osteoporosis
Odanacatib
Merck 's odanacatib potential overlooked, says Credit Suisse
Yahoo/Fly on the Wall
Mon, 06/25/12 - 11:03 am
Odanacatib
Merck
osteoporosis
Mylan Launches Generics for Bonviva and Viramune
Yahoo/Zacks
Mon, 05/28/12 - 11:14 am
Mylan
Bonviva
generics
Europe
UK
Roche
Boehringer Ingelheim
osteoporosis
HIV
Viramune
InterMune to Sell Actimmune Rights
Yahoo/Zacks.com
Tue, 05/22/12 - 09:40 am
InterMune
Actimmune
Vidara
osteoporosis
FDA approves first low-cost versions of osteoporosis drug from 3 generic drugmakers
Yahoo/AP
Tue, 03/20/12 - 10:04 am
generics
FDA
osteoporosis
Boniva
Apotex
Orchid Healthcare
Mylan
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:00 pm
Prolia
osteoporosis
Amgen
Bone Drugs Need Label Changes on Use Duration, Panel Says
Bloomberg
Sat, 09/10/11 - 10:40 am
Warner Chilcott
Roche
Merck
Novartis
osteoporosis
bone growth
Actonel
Boniva
Reclast
Fosamax
FDA Panel Considers Bone-Drug Safety
WSJ Online
Tue, 09/6/11 - 12:13 pm
FDA
biophosphonates
osteoporosis
US judge narrows benchmark Fosamax case vs. Merck
Reuters
Wed, 08/31/11 - 12:56 pm
Merck
Fosamax
osteoporosis
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
Bloomberg
Thu, 07/21/11 - 02:01 pm
FDA
osteoporosis
esophageal cancer
Roche
Novartis
bisphosphonates
Merck
Boniva
Reclast
Fosamax
Tarsa gets more financing for oral osteoporosis drug
Bizjournals.com
Tue, 07/12/11 - 12:06 pm
Tarsa
osteoporosis
Calcitonin

Pages